Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313233435> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4313233435 endingPage "329" @default.
- W4313233435 startingPage "329" @default.
- W4313233435 abstract "Obesity is widely reported to be associated with a higher risk of the severity and worse clinical outcome of COVID-19. With the global prevalence of obesity, exploring the relationship between obesity and the severity of COVID-19 disease is of major clinical importance, thus requiring increased attention to preventive measures in susceptible individuals. Studies have shown that obesity is associated with increased risk of hospitalisation, intensive care unit admission, integrated motivational–volitional requirement and mortality among patients with COVID-19. The pathophysiological mechanisms which cause disease severity and adverse outcomes among obese subjects remain unclear. Recently, it was shown that elevated leptin levels correlate positively with the severity and progression of disease in COVID-19 patients. Leptin modulates both the innate and adaptive immune responses in cells. Elevated leptin levels in obese individuals may contribute to worse symptoms and outcomes in COVID-19 disease. Emerging evidence suggests that alpha-1 (α1)-adrenergic receptor stimulation increases leptin secretion, while the administration of α1-adrenergic receptor antagonists is reported to reduce plasma leptin levels in human subjects. Therefore, α1-adrenergic receptor antagonists may improve clinical outcomes in obesity patients with COVID-19 infection through modulation of hyperinflammation and reduction of plasma leptin levels. The aim of this minireview is to delineate the potential beneficial therapeutic effects of α1-adrenergic receptor antagonists in preventing adverse outcomes of coronavirus infection in obese patients. Large, randomised trials are needed to confirm the beneficial effects and safety profile of the use of α1-adrenergic receptor antagonists in obese patients with COVID-19." @default.
- W4313233435 created "2023-01-06" @default.
- W4313233435 creator A5017055262 @default.
- W4313233435 creator A5023806087 @default.
- W4313233435 creator A5031272122 @default.
- W4313233435 creator A5045828079 @default.
- W4313233435 date "2022-01-01" @default.
- W4313233435 modified "2023-10-01" @default.
- W4313233435 title "The use of α1-adrenergic receptor antagonists in the prevention of adverse outcomes of COVID-19 infection in obese patients" @default.
- W4313233435 cites W1583337622 @default.
- W4313233435 cites W2000530357 @default.
- W4313233435 cites W2043458888 @default.
- W4313233435 cites W2056768166 @default.
- W4313233435 cites W2086632723 @default.
- W4313233435 cites W2124380083 @default.
- W4313233435 cites W2410598399 @default.
- W4313233435 cites W2902776732 @default.
- W4313233435 cites W2903675281 @default.
- W4313233435 cites W3003324146 @default.
- W4313233435 cites W3014003872 @default.
- W4313233435 cites W3021770664 @default.
- W4313233435 cites W3039730521 @default.
- W4313233435 cites W3040913740 @default.
- W4313233435 cites W3045046254 @default.
- W4313233435 cites W3048729071 @default.
- W4313233435 cites W3048869410 @default.
- W4313233435 cites W3088166068 @default.
- W4313233435 cites W3109296221 @default.
- W4313233435 cites W3120161580 @default.
- W4313233435 cites W3122076537 @default.
- W4313233435 cites W3126241755 @default.
- W4313233435 cites W3128644239 @default.
- W4313233435 cites W3172555800 @default.
- W4313233435 doi "https://doi.org/10.4103/aihb.aihb_177_21" @default.
- W4313233435 hasPublicationYear "2022" @default.
- W4313233435 type Work @default.
- W4313233435 citedByCount "0" @default.
- W4313233435 crossrefType "journal-article" @default.
- W4313233435 hasAuthorship W4313233435A5017055262 @default.
- W4313233435 hasAuthorship W4313233435A5023806087 @default.
- W4313233435 hasAuthorship W4313233435A5031272122 @default.
- W4313233435 hasAuthorship W4313233435A5045828079 @default.
- W4313233435 hasBestOaLocation W43132334351 @default.
- W4313233435 hasConcept C126322002 @default.
- W4313233435 hasConcept C134018914 @default.
- W4313233435 hasConcept C14372207 @default.
- W4313233435 hasConcept C158453852 @default.
- W4313233435 hasConcept C170493617 @default.
- W4313233435 hasConcept C197934379 @default.
- W4313233435 hasConcept C2779134260 @default.
- W4313233435 hasConcept C2780613262 @default.
- W4313233435 hasConcept C511355011 @default.
- W4313233435 hasConcept C60644358 @default.
- W4313233435 hasConcept C71924100 @default.
- W4313233435 hasConcept C86803240 @default.
- W4313233435 hasConceptScore W4313233435C126322002 @default.
- W4313233435 hasConceptScore W4313233435C134018914 @default.
- W4313233435 hasConceptScore W4313233435C14372207 @default.
- W4313233435 hasConceptScore W4313233435C158453852 @default.
- W4313233435 hasConceptScore W4313233435C170493617 @default.
- W4313233435 hasConceptScore W4313233435C197934379 @default.
- W4313233435 hasConceptScore W4313233435C2779134260 @default.
- W4313233435 hasConceptScore W4313233435C2780613262 @default.
- W4313233435 hasConceptScore W4313233435C511355011 @default.
- W4313233435 hasConceptScore W4313233435C60644358 @default.
- W4313233435 hasConceptScore W4313233435C71924100 @default.
- W4313233435 hasConceptScore W4313233435C86803240 @default.
- W4313233435 hasIssue "3" @default.
- W4313233435 hasLocation W43132334351 @default.
- W4313233435 hasLocation W43132334352 @default.
- W4313233435 hasOpenAccess W4313233435 @default.
- W4313233435 hasPrimaryLocation W43132334351 @default.
- W4313233435 hasRelatedWork W1976946227 @default.
- W4313233435 hasRelatedWork W1986171586 @default.
- W4313233435 hasRelatedWork W1994686423 @default.
- W4313233435 hasRelatedWork W2022716990 @default.
- W4313233435 hasRelatedWork W2100782952 @default.
- W4313233435 hasRelatedWork W2138466941 @default.
- W4313233435 hasRelatedWork W2141130683 @default.
- W4313233435 hasRelatedWork W2148844770 @default.
- W4313233435 hasRelatedWork W2416108475 @default.
- W4313233435 hasRelatedWork W2772070342 @default.
- W4313233435 hasVolume "12" @default.
- W4313233435 isParatext "false" @default.
- W4313233435 isRetracted "false" @default.
- W4313233435 workType "article" @default.